VMP-CIsCF protocol

Preferred Label : VMP-CIsCF protocol;

MeSH note : chemotherapy protocol used in the treatment of prostate cancer; consists of vincristine, peplomycin, methotrexate, cisplatin, cytarabine, & fluorouracil;

Is substance : O;

Détails

Origin ID

C059163;

UMLS CUI

C0636710;

MeSH term(s) associated for indexing
- antineoplastic combined chemotherapy protocols [MeSH Descriptor]
- cisplatin [MeSH Descriptor]
- cytarabine [MeSH Descriptor]
- fluorouracil [MeSH Descriptor]
- methotrexate [MeSH Descriptor]
- peplomycin [MeSH Descriptor]
- vincristine [MeSH Descriptor]
Record concept(s)
- VMP-CIsCF protocol [MeSH concept]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

All resources
or only the major
or use the search engine

recommendations
documents concerning education
documents for patients